Page last updated: 2024-12-06

dimidium

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

dimidium: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID68208
CHEMBL ID344648
SCHEMBL ID2014260
MeSH IDM0108211

Synonyms (17)

Synonym
(3-amino-5-methyl-6-phenyl-phenanthridin-5-ium-8-yl)amine;bromide
bdbm18
cid_68207
5-methyl-6-phenyl-phenanthridin-5-ium-3,8-diamine;bromide
dimidium
5-methyl-6-phenyl-phenanthridin-5-ium-3,8-diamine
3,8-diamino-5-methyl-6-phenylphenanthridinium
CHEMBL344648
20566-69-2
5-methyl-6-phenylphenanthridin-5-ium-3,8-diamine
phenanthridinium, 3,8-diamino-5-methyl-6-phenyl-
NCGC00247021-01
STL483482
SCHEMBL2014260
3,8-diamino-5-methyl-6-phenyl-phenanthridinium ,
DTXSID10870579
3,8-diamino-5-methyl-6-phenylphenanthridin-5-ium

Research Excerpts

Toxicity

ExcerptReferenceRelevance
"A natural DNA-intercalator plant benzo-c-phenanthridine alkaloid sanguinarine is more toxic for mouse transformed fibroblast L-cells in culture than synthetic DNA-intercalator ethidium bromide (EtB) and alkaloid berberine."( [The toxicity of sanguinarine compared to a number of other DNA-tropic compounds for ethidium bromide-sensitive and -resistant transformed murine fibroblasts in culture].
Beliaeva, TN; Faddeeva, MD; Ignatova, TN; Sal'nikov, KV, 1989
)
0.28
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID26756DNA binding dissociation constant as KD1984Journal of medicinal chemistry, Apr, Volume: 27, Issue:4
Interactions of antitumor drugs with natural DNA: 1H NMR study of binding mode and kinetics.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (18)

TimeframeStudies, This Drug (%)All Drugs %
pre-199016 (88.89)18.7374
1990's1 (5.56)18.2507
2000's0 (0.00)29.6817
2010's1 (5.56)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 46.69

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index46.69 (24.57)
Research Supply Index2.94 (2.92)
Research Growth Index4.11 (4.65)
Search Engine Demand Index68.69 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (46.69)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other18 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]